2025 Update in Hematology and Medical Oncology — On Demand

Overview

2025 Update in Hematology and Medical Oncology — On Demand is the 13th Annual Board Review and Comprehensive Update providing an in-depth and current review of diagnosis, staging, and management of neoplastic diseases, including solid tumors and hematologic malignancies. This expert-led program encompasses disease-specific lectures and discussions across a broad range of cancers such as gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, central nervous system cancers, and hematologic malignancies.

On-demand Oncology & Hematology education — accessible anytime, anywhere.

Format: Videos plus PDFs

Agenda

This comprehensive update covers key topics across hematology and medical oncology, delivered by recognized specialists. The agenda includes the following presentations:

• Colon Cancer — Leonard Saltz, MD
• Melanoma — Michael A. Postow, MD
• Kidney Cancer — Robert J. Motzer, MD
• Prostate Cancer — Susan F. Slovin, MD, PhD
• Mesothelioma — Michael D. Offin, MD
• Urothelial Cancer — Gopa Iyer, MD
• Testis Cancer — Darren R. Feldman, MD
• Uterine, Cervix, and Other Gynecologic Cancers — Carol Aghajanian, MD
• Ovarian Cancer — Rachel N. Grisham, MD
• Breast Cancer Surgery — Anita Mamtani, MD, FACS
• Breast Cancer Radiation Therapy — Lior Z. Braunstein, MD
• Hereditary Cancer Genetics — Zsofia K. Stadler, MD
• Small Cell Lung Cancer — Alissa J. Cooper, MD
• HER2-Positive Breast Cancer — Joshua Z. Drago, MD, MS
• Triple-Negative Breast Cancer — Rachel Sanford, MD
• Hormone Receptor-Positive Breast Cancer — Devika Gajria, MD
• Carcinoma of Unknown Primary — Anna M. Varghese, MD
• Hepatocellular Cancer and Cholangiocarcinoma — Ghassan K. Abou-Alfa, MD, JD, MBA
• Pancreatic and Neuroendocrine Cancers — Eileen M. O’Reilly, MD
• Non-Small Cell Lung Cancer — Gregory J. Riely, MD, PhD
• Head and Neck, Thyroid, and Non-Melanoma Skin Cancers — Lara A. Dunn, MD
• Anal and Rectal Cancers — Andrea Cercek, MD
• Esophageal and Gastric Cancers — David H. Ilson, MD, PhD, FACP, FASCO
• Central Nervous System Tumors — Thomas J. Kaley, MD
• Sarcoma — Robert Maki, MD, PhD
• Infectious Disease — Susan K. Seo, MD
• Pharmacology I & II — Mrinal M. Gounder, MD
• Acute Myeloid Leukemia — Eytan M. Stein, MD
• Low-Grade Non-Hodgkin Lymphoma — Andrew D. Zelenetz, MD, PhD
• Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma — Meghan C. Thompson, MD
• Diffuse Large B-Cell Lymphoma / Mantle Cell Lymphoma / Burkitt Lymphoma — Paul A. Hamlin, MD
• Hodgkin Lymphoma / T Cell — Alison J. Moskowitz, MD
• Auto / Allogeneic Transplantation — Gunjan L. Shah, MD
• CAR T Cells — Craig Sauter, MD
• Acute Lymphocytic Leukemia — Mark B. Geyer, MD
• Myeloproliferative Neoplasms — Raajit K. Rampal, MD, PhD
• Myelodysplastic Syndromes — Aaron D. Goldberg, MD, PhD
• Chronic Myelogenous Leukemia — Michael J. Mauro, MD
• Myeloma / Amyloid — Malin Hultcrantz, MD, PhD
• Approach to the Bleeding Patient — Avi Leader, MD
• Thrombotic Disorders — Jeffrey Zwicker, MD
• Antithrombotic and Antiplatelet Therapy — Simon Mantha, MD, MPH
• Thrombocytopenia and ITP — Cy R. Wilkins, MD
• Sickle Cell Disease, Thalassemia — Susanna Curtis, MD, PhD
• Hemolytic Anemia — Gerald A. Soff, MD
• Clinical Indications for Use of Blood Products and Associated Risks — P. Dayand Borge, MD, PhD
• Transfusion Reactions

Speakers

The program features a distinguished faculty of expert clinicians and researchers primarily from Memorial Sloan Kettering Cancer Center and affiliated institutions. These specialists represent a range of expertise within hematology, medical oncology, oncology subspecialties, and related fields, delivering evidence-based updates to support clinical practice and examination preparedness.

Target Audience

This course is designed for hematologists, medical oncologists, oncology subspecialists, internal medicine physicians, and other healthcare professionals involved in the diagnosis, treatment, and management of cancer patients seeking to update their knowledge or prepare for board certification and recertification in hematology and medical oncology.

Why This Topic Matters

2025 Update in Hematology and Medical Oncology — On Demand provides a comprehensive review of advances in this rapidly evolving specialty, supporting clinicians in strengthening their expertise in cancer care. This update is relevant for professionals who require current evidence-based information on hematologic and solid tumor malignancies to inform clinical decisions effectively.

Hosted on MedHub Central, this on-demand format allows learners to engage with expert content tailored to the oncology and hematology specialty at their convenience, facilitating comprehensive exam preparation and ongoing clinical proficiency.